Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.10.5047

Estrogen Receptor and Progesterone Receptor Status in Breast Cancer in Relation to Age, Histological Grade, Size of Lesion and Lymph Node Involvement  

Sofi, Gulam Nabi (Pathologyskims)
Sofi, Junaid Nabi (Khalida Zia Medical College)
Nadeem, Raja (GMC)
Shiekh, Rayees Yousuf (SKIMS)
Khan, Faroze Ahmad (SKIMS)
Sofi, Abid Ahmad (SKIMS)
Bhat, Hillal Ahmad (SKIMS)
Bhat, Rayees Ahmad (SKIMS Medical College)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.10, 2012 , pp. 5047-5052 More about this Journal
Abstract
Introduction: Breast cancer is the most common malignancy of women in Kashmir. This study was conducted with the objective of assessing hormone receptor positivity and its correlation with age at diagnosis, tumor size, histological grade and lymph node metastasis. Materials and Methods: 132 newly diagnosed cases of invasive breast cancer diagnosed at the Department of Pathology, SKIMS, Srinagar, J&K, were included after excluding biopsies, in-situ lesions and recurrence cases. Results: Mean age of the patients was 48.2 years, 59.1% being ${\leq}50$ years of age. Mean duration of symptoms was 6.32 months. Most lesions (65.1%) were 2-5 cm and 16.7% were ${\geq}5.0$ cm in greatest dimension. The predominant (80.3%) morphology was IDC-NOS. The majority of the cases presented as grade II (52.1%) lesions and lymph node involvement was present in 65.2%. ER and PR were positive in 66.3% and 63.4% cases, respectively, increasing with rising age. High grade lesions and larger size tumors were more likely to be ER and PR negative. No correlation was found between ER/PR status and lymph node metastasis. Conclusions: ER and PR expression in breast cancers in the current study was found to be higher than studies done in India/Asia but lower than studies conducted in the West, even on Indian/Asian immigrants. Markedly lower receptor expression in Indian/Asian studies is likely due to preanalytic variables, thresholds for positivity, and interpretation criteria. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer are strongly advocated for standardization of receptor evaluation and for clinical management of breast cancer patients to provide best therapeutic options.
Keywords
Breast cancer; estrogen receptor; progestrone receptor; preanalytic variables;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Mori I, Yang Q, Kakudo K (2002). Predictive and prognostic markers for invasive breast cancer. Pathol Int, 52, 186-94   DOI
2 Mudduva LK (2009). Quick score of hormone receptor status of breast carcinoma: correlation with other clinicopathological prognostic parameters. Indian J Pathol Microbiol, 52, 159-63   DOI
3 Murthy NS, Agarwal UK, Chaudhry K, Saxena S (2007). A study on time trends in incidence of breast cancer - Indian scenario. Eur J Cancer Care, 16, 185-6   DOI
4 Naeem M, Khan N, Aman Z, et al (2008). Pattern of breast cancer: experience at lady reading hospital, Peshawar J Ayub Med Coll Abbottabad, 20, 22-5.
5 Navani S, Bhaduri AS (2005). High incidence of oestrogen receptor negative progesterone receptor positive phenotype in Indian breast cancer: Fact or fiction? Indian J Pathol Microbiol, 48, 199-201
6 Nguyen Pl, Taghian AG, Katz MS, et al (2008). Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and Her-2 is associated with local and distant recurrence after breast- conserving therapy. J Clin Oncol, 26, 2373-8.   DOI
7 Nielsen To, Hsu Fd, Jensen K, et al (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res, 10, 5367-74.   DOI   ScienceOn
8 Onitilo AA, Engel JM, Greenlee RT, Mukesh BN (2009). Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival. Clin Med Res 7, 4-13.   DOI
9 Parkin Dm, Bray F, Ferlay J, Pisani P (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6.   DOI   ScienceOn
10 Shet, TWO AUTHOR, et al (2009). Hormone receptors over last 8 years in a cancer referral center in India: What was and what is?. Indian J Pathol and Microbiology, 52, 171-4   DOI
11 Sorlie T, Perou Cm, Tibshirani R, et al (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74.   DOI   ScienceOn
12 Sorlie T, Tibshirani R, Parker J, et al (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA, 100, 8418-23.   DOI
13 Sotiriou C, Neo Sy, Mcshane Lm, et al (2003). Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA, 100, 10393-8.   DOI
14 Suvarchala SB, Nageswararao R(2011). Carcinoma Breast histopathological and hormone receptors correlation. J Biosci Tech, 2, 340-8
15 World Cancer Report. International Agency For Research On Cancer. June 2003. Retrieved 2009-03-26.
16 Wu TY, West B, Chen YW, Hergert C (2006). Health beliefs and practices related to breast cancer screening in Filipino, Chinese and Asian-Indian women. Cancer Detect Prev, 30, 58-66.   DOI
17 Bolufer P, Molina R, Ruiz A, et al (1994). Estradiol receptors in combination with neu or myc oncogene amplifications might define new subtypes of breast cancer. Clin Chim Acta, 229, 107-22.   DOI
18 Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM (2003). Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol, 21, 1973-9.   DOI
19 Barnes Dm, Hanby Am (2001). Oestrogen And Progesterone Receptors In Breast Cancer: Past, Present And Future. Histopathology, 38, 271-4.   DOI
20 Blesch KS, Davis F, Kamath SK (1999). A comparison of breast and colon cancer incidence rates among native Asian Indians, US immigrant Asian Indians, and whites. J Am Diet Assoc, 99, 1275-7.   DOI
21 Deshpande AD, Jeffe DB, Gnerlich J, et al (2009). Racial Disparities in Breast Cancer Survival: An Analysis by Age and Stage. J Surg Res, 153, 105-13.   DOI
22 Couris CM, Polazzi S, Olive F, et al (2009). Breast cancer incidence using administrative data: correction with sensitivity and specificity. J Clin Epidemiol, 62, 660-6.   DOI
23 Deapen D, Liu L, Perkins C, Bernstein L, Ross RK (2002). Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer, 99, 747-50.   DOI
24 Desai SB, Moonim MT, Gill AK, et al (2000). Hormone receptor status of breast cancer in India: a study of 798 tumors. Breast, 9, 267-70.   DOI
25 Dunnwald LK, Rossing MA, Li CI (2007). Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res, 9, R6.   DOI
26 Early Breast Cancer Trialists' Collaborative Group (1998). Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet, 35, 1451-67.
27 Fact Sheet No. 297: Cancer. World Hlth Organization. February 2006. Retrieved 2009-03-26.
28 Fatima, TWO AUTHOR, et al (2005). Breast cancer: steroid receptors and other prognostic indicators. J Coll Physicians Surg Pak. 15, 230-3.
29 Fisher ER, Anderson S, Dean S, et al (2005). Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma. Cancer, 103, 164-73.   DOI
30 Gajalakshmi P, Natarajan TG, Selvi Rani D, Thangaraj K (2007). A novel BRCA1 mutation in an Indian family with hereditary breast/ovarian cancer. Breast Cancer Res Treat, 101, 3-6.   DOI
31 Gown MA (2008). Current issues in ER and HER2 testing by IHC in breast cancer, Modern Pathol, 21, 8-15.   DOI
32 Ghumare SS, Cunningham JE (2007). Breast cancer trends in Indian residents and emigrants portend an emerging epidemic for India. Asian Pac J Cancer Prev, 8, 507-12.
33 Goggins WB, Wong G (2009). Cancer among Asian Indians/ Pakistanis living in the United States: low incidence and generally above average survival. Cancer Causes Control, 20, 635-43.   DOI
34 Goldhirsch A, Glick JH, Gelber RD, et al (2005). Meeting highlights: international expert consensus on the primary therapy of early breast cancer. Ann Oncol, 16, 1569-83.   DOI   ScienceOn
35 Hammond ME, Hayes DF, Dowsett M, et al (2010). American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer arch pathol lab med. Arch Pathol Lab Med, 134, 907-22.
36 Harvey JM, Clark GM, Osborne CK, et al (1999). Estrogen receptor status by immunohistochemistry is superior to the ligandbinding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol, 17, 1474-81
37 Hawkins RA, Roberts MM, Forrest APM (1980). Estrogen receptors and breast cancer. Current status. Br J Surg, 67, 162-5.
38 Hebert JR, Ghumare SS, Gupta PC (2006). Stage at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States. Asian Pac J Cancer Prev, 7, 547-55.
39 Irvin WJ Jr, Carey LA (2008). What is triple-negative breast cancer? Eur J Cancer, 44, 2799-805.   DOI
40 Jack RH, Davies EA, Moller H (2009). Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England. Br J Cancer, 100, 545-50.   DOI
41 Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.   DOI   ScienceOn
42 Kakarala M, Rozek L, Cote M, Liyanage S, Brenner DE (2010). Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S. - a SEER analysis. BMC Cancer, 10, 191.   DOI
43 Kamath SK, Murillo G, Chatterton RT Jr, et al (1999). Breast cancer risk factors in two distinct ethnic groups: Indian and Pakistani vs. American premenopausal women. Nutr Cancer, 35, 16-26.   DOI
44 Kuraparthy S, Reddy KM, Yadagiri LA, et al (2007). Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in Southern India. World J Surg Oncol, 5, 56.   DOI   ScienceOn
45 La Vecchia C, Franceschi S, Lucchini F, Levi F (1994). International variations and trends in the incidence of breast Cancer in Older Women. Cancer Control, 1, 327-33.
46 Marugame T, Katanoda K (2006). International comparisons of cumulative risk of breast and prostate cancer, from cancer incidence in five continents Vol. VIII. Jpn J Clin Oncol, 36, 399-400.   DOI
47 Mohsin SK, Weiss H, Havighurst T, et al (2004). Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol, 17, 1545-54.   DOI
48 Morabia A, Costanza MC (2000). Reproductive factors and incidence of breast cancer: an international ecological study. Soz Praventivmed, 45, 247-57.   DOI
49 Raina V, Bhutani M, Bedi R, et al (2005). Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer, 42, 40-5   DOI
50 Perou Cm, Sorlie T, Eisen Mb, et al (2000). Molecular portraits of human breast tumours. Nat, 406, 747-52.   DOI   ScienceOn
51 Raju GC, Naraynsingh V (1989). Breast cancer in West Indian women in trinidad. Trop Geogr Med, 41, 257-60.
52 Rambau PF, Chalya PL, Manyama MM, Jackson KJ (2011). Pathological features of breast cancer seen in Northwestern Tanzania: a nine years retrospective study. BMC Res Notes, 4, 214   DOI
53 Rampaul RS, Pinder SE, Elaston CW, Ellis IO (2001). Prognostic and predictive factors in primary breast cancer and their role in patient management; the Nottingham breast team. Eur J Surg Oncol, 27, 229-38   DOI   ScienceOn
54 Rao R, Kuerer H, Cristofanilli M, et al (2008). Breast cancer in the asian Indian population of the United States: a call for screening and education. Breast J, 14, 402-3.   DOI
55 Rastogi T, Devesa S, Mangtani P, et al (2008). Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int J Epidemiol, 37, 147-60.   DOI   ScienceOn
56 Rosen M, Lundin A, Nystrom L, et al (2000). (Incidence and mortality of breast cancer during a 25-year period. International and regional comparisons). Lakartidningen, 97, 294-9.
57 Setiawan VW, Monroe KR, Wilkens LR, et al (2009). HendersonBreast cancer risk factors defined by estrogen and progesterone receptorstatus. Am J Epidemiol, 169, 1251-9.   DOI